The unibody (Powerlink/AFX/AFX2) Endovascular AAA device (Endologix Inc., CA, USA) presents a unique design with its long main body and two innate limbs. The device is designed to be deployed and sits on the native aortoiliac bifurcation and represents the only one-piece bifurcated endograft designed to use anatomical fixation for endograft stabilization. According to published literature, the unibody device seems to represent a valid choice in the treatment of abdominal aortic aneurysms. This particular device would seem to satisfactorily perform even in the treatment of more compressed aneurysms (also in off-label association with parallel grafts) and in occlusive pathologies. Ongoing studies will provide new real-life data in a large and unselected patient population to better understand the device's advantages and limitations.
Unibody bifurcated aortic endograft: device description, review of the literature and future perspectives / Sirignano, Pasqualino; Silingardi, Roberto; Mansour, WASSIM AHMAD; Andreoli, Francesco; Migliari, Mattia; Speziale, Francesco. - In: FUTURE CARDIOLOGY. - ISSN 1479-6678. - (2021). [10.2217/fca-2020-0119]
Unibody bifurcated aortic endograft: device description, review of the literature and future perspectives
Pasqualino Sirignano
Primo
Writing – Original Draft Preparation
;Wassim Mansour;
2021
Abstract
The unibody (Powerlink/AFX/AFX2) Endovascular AAA device (Endologix Inc., CA, USA) presents a unique design with its long main body and two innate limbs. The device is designed to be deployed and sits on the native aortoiliac bifurcation and represents the only one-piece bifurcated endograft designed to use anatomical fixation for endograft stabilization. According to published literature, the unibody device seems to represent a valid choice in the treatment of abdominal aortic aneurysms. This particular device would seem to satisfactorily perform even in the treatment of more compressed aneurysms (also in off-label association with parallel grafts) and in occlusive pathologies. Ongoing studies will provide new real-life data in a large and unselected patient population to better understand the device's advantages and limitations.File | Dimensione | Formato | |
---|---|---|---|
Sirignano_Unibody-bifurcated-aortic-endograft_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
2.36 MB
Formato
Adobe PDF
|
2.36 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.